Month: September 2026

Company to use The Bracket^™ platform to monitor trading patterns, identify potential abnormalities and support market transparency

New York, NY, Sept. 17, 2026 (GLOBE NEWSWIRE) — Mixed Martial Arts Group Limited (NYSE American: MMA) (“MMA” or the “Company”), doing business as MMA.INC, today announced that it has entered into a service agreement with Generation IACP Inc. to provide enhanced monitoring, analysis and reporting of trading activity in the Company’s ordinary shares.

The engagement forms part of MMA.INC’s broader commitment to market integrity, strong corporate governance and the protection of shareholder interests.

Through Generation IACP’s The Bracket™ platform, professional traders will conduct ongoing analysis of trading patterns, market-participant behaviour and significant institutional share movements. Generation IACP will apply proprietary methodologies designed to identify potential abnormalities and activity associated with aggressive selling, short selling, anonymous trading and potentially prohibited trading practices.

The engagement will give MMA.INC’s Board and management more timely and granular insight into the trading of the Company’s shares, strengthen the Company’s ability to identify activity warranting further scrutiny and provide an evidentiary basis for determining whether additional action is appropriate.

Nick Langton, Founder and Chief Executive Officer of MMA.INC, said:

“Protecting shareholder interests requires active oversight of how our securities trade, careful scrutiny of unusual activity and a readiness to act when credible evidence emerges.

“MMA.INC will not be a passive observer where trading activity raises legitimate concerns. Under this engagement, trading in our shares will be subject to enhanced professional monitoring and rigorous, data-driven analysis. Market participants should understand that anomalous activity may be identified, analyzed and documented.

“Our position is straightforward: we support a fair, transparent and orderly market for MMA shares. If this work produces substantiated evidence of misconduct, we will act promptly and firmly through every appropriate market, legal, regulatory or enforcement channel available to the Company.”

MMA.INC intends to evaluate all material findings with its legal and other advisers. Where warranted, the Company may refer relevant information to market operators, broker-dealers, regulators or other enforcement authorities and pursue any additional measures considered appropriate to protect the Company and its shareholders.

The Company has not reached any conclusion that unlawful trading has occurred. The purpose of the engagement is to establish the facts through rigorous professional analysis and ensure MMA.INC is equipped to respond decisively to any credible evidence identified.

About Generation IACP Inc. and The Bracket^™

Generation IACP Inc. is a Canadian investment dealer and member of the Canadian Investment Regulatory Organization. Its issuer-services platform, The Bracket^™, provides publicly listed companies with market surveillance, trading analytics and timely reporting designed to improve their understanding of market activity and identify anomalous trading patterns.

For more information, visit www.bracketreport.com.

About Mixed Martial Arts Group Limited

Mixed Martial Arts Group Limited (NYSE American: MMA), doing business as MMA.INC, is building the participation and technology platform for the global martial arts and combat sports industry, connecting practitioners, gyms, coaches, content, commerce and payments.

As of July 2026, MMA.INC’s platform assets included 5 million+ social media followers, 680,000 user profiles, 107,694 registered student profiles, 27,651 monthly active users and 15,326 published gym profiles, including 996 verified and 389 paying academies. The platform also recorded approximately 80,000 monthly check-ins and an annualized payments run rate of approximately US$21 million based on May 2026 processing volumes.

• A Connected Participation Platform: MMA.INC brings together gym software, payments, training, community, content and commerce through assets including BJJLink, TrainAlta, Hype and MixedMartialArts.com.
• A Growing Participation Network: Over the prior 18 months, registered student profiles increased approximately 101%, monthly active users approximately 89% and paying academies approximately 260%.
• Built to Aggregate the Sector: MMA.INC’s strategy is to connect the fragmented martial arts participation economy through a unified digital identity and ecosystem designed to deepen engagement and expand monetization across software, payments, programs, memberships, partnerships and commerce.

For more information, visit www.mma.inc

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Sections 27A of the Securities Act of 1933 and 21E of the Securities Exchange Act of 1934. Words such as “believe,” “may,” “estimate,” “anticipate,” “intend,” “plan,” “could,” “target,” “potential,” “will,” “expect” and similar expressions are intended to identify forward-looking statements. These statements include, without limitation, statements regarding the anticipated scope, benefits and results of the Company’s engagement with Generation IACP; the ability of the monitoring and analysis to identify anomalous or potentially improper trading activity; the Company’s evaluation of any findings; any market, legal, regulatory or enforcement action the Company may take; and MMA.INC’s strategy, plans and objectives, growth and monetization of its platform, increased penetration of existing users, students, gyms and other platform assets, development and adoption of products and programs, partnerships, geographic expansion, acquisitions, strategic investments, payment volumes, and future revenue, margins, operating performance and financial condition. Forward-looking statements are based on management’s current expectations, assumptions and estimates and are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. These include, among others, the Company’s ability to manage growth; the adoption and commercialization of its products and services; its dependence on gyms, academies, members, partners and key relationships; competition; execution and integration risks associated with acquisitions; regulatory developments; macroeconomic conditions; access to capital; and the risks described in the Company’s Annual Report on Form 20-F and subsequent reports on Form 6-K filed with or furnished to the U.S. Securities and Exchange Commission. There can be no assurance that the engagement with Generation IACP will identify improper or unlawful activity, identify any responsible party, produce conclusive findings, result in any referral, investigation or legal or regulatory action, or affect the trading market or price of the Company’s ordinary shares. Available trading data may be incomplete or inconclusive, and trading patterns that appear unusual may result from lawful activity. There can be no assurance that any forward-looking outcome will be achieved. MMA.INC’s products and business lines are at varying stages of development, commercialization and adoption, and certain products, services or features may be modified, delayed or discontinued. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update or revise any forward-looking statement except as required by applicable law.

Media Contacts

Mixed Martial Arts Group Limited
E: andrew@mma.inc

Sept. 19 celebration features live music, throwback beers and throwback prices, food trucks, axe throwing, flash tattoos, giveaways and more

BEND, Ore., Sept. 17, 2026 (GLOBE NEWSWIRE) — 10 Barrel Brewing, the Bend-born craft beer brand known for bold beers, big personality, and bringing people together for a good time, by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), is marking its 20th anniversary with a celebration at the 10 Barrel East Side pub on September 19 from 4:00 to 9:00 p.m.

“Twenty years ago, 10 Barrel started with three friends, a love of great beer, and a simple idea: brew beer, drink beer, and have fun doing it,” said Brian Hughes, Sr. Brand Director. “That same spirit still drives us today. Bend has been part of our story from the beginning, so we’re celebrating the community that helped build 10 Barrel with a birthday bash full of old-school beers, throwback prices, live music, and plenty of the unexpected. Come raise a glass with us.”

The 20th Anniversary Party is built for a full night of beer, music and Bend-style fun, with DJ Indica Jones, Amargosa, Rubah Tree and Precious Byrd bringing the soundtrack alongside food trucks, local vendors and throwback beers like Joe IPA, ISA and OG Wheat at throwback prices.

Guests can keep the party going with axe throwing, a photo booth, free flash tattoos, giveaways and plenty of unexpected moments throughout the celebration.

10 Barrel Brewing encourages guests 21+ to drink responsibly.

Event Details

• What: 10 Barrel Brewing 20th Anniversary Party
• When: Saturday, Sept. 19, 2026, 4 to 9 p.m.
• Where: 10 Barrel East Side, 62950 NE 18th Street, Bend, OR 97701
• Live music: DJ Indica Jones; Amargosa; Rubah Tree; Precious Byrd
• Activities: Axe throwing; photo booth; free flash tattoos; giveaways; local vendors; food trucks; throwback beers and throwback prices

For more information about 10 Barrel Brewing and its pub locations, visit 10Barrel.com and follow @10barrelbrewing on social media.

About 10 Barrel Brewing Co.

10 Barrel Brewing Company is a craft brewery based in Bend, Oregon, featuring innovative beers brewed locally at each of its four brewpub locations in Bend, Portland, and Boise. 10 Barrel has one simple mindset: Brew beer, drink beer, and have fun doing it. For more information, visit 10 Barrel Brewing and follow @10barrelbrewing on social.

About Tilray Brands  
Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.

For further information, please contact

Media: news@tilray.com

Investors: investors@tilray.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e98db391-015f-4169-a6f6-a08be2eefb44

PARIS, NEW YORK and WHEAT RIDGE, Colo., Sept. 17, 2026 (GLOBE NEWSWIRE) — USA Rare Earth (Nasdaq: USAR), a rare earth, critical minerals and advanced materials company, Pasqal (Nasdaq: PSQL), a global leader in neutral-atom quantum computing and Riven Systems, a specialist in AI for industrial chemistry, today announced a strategic partnership to develop next-generation separation technology for the rare earth value chain. Using quantum machine learning, the project aims to identify new separation molecules that bind more effectively to rare earths than existing alternatives, enabling smaller, lower-cost, less energy-intensive processing facilities.

The collaboration brings together U.S. and French expertise in two strategically important sectors: critical minerals and quantum computing. Together, the companies aim to explore technologies that could help support a more secure, efficient and competitive Western rare earth supply chain.

The partnership brings together Riven’s self-driving minerals separation laboratory and Pasqal’s quantum computing power with USA Rare Earth’s rare earth processing expertise. Under the planned project, Riven would conduct thousands of automated experiments and generate the training data needed to build machine learning models of extractant selectivity for rare earth elements. Pasqal’s Neutral Atom QPU would then benchmark quantum machine learning models against classical computing-based models (each trained on data from the self-driving lab) to support USA Rare Earth in optimizing extractant selection.

“The key challenge the rare earth industry outside Asia faces is to separate the Mixed Rare Earth Carbonate (MREC) produced in upstream operations into individual, separated oxides. The Chinese dominate this capability, especially for vital heavy rare earths such as dysprosium, terbium and yttrium. Our goal is to accelerate the path to efficient, competitive and sustainable solutions by changing how the rare earth industry discovers the chemistry it runs on, replacing years of trial-and-error,” remarked Alex Moyes, Senior Vice President of Upstream (USA), USA Rare Earth. “This strategic partnership will institute an innovative discovery pipeline where new extractant molecules are identified and tested virtually, powered by a quantum machine learning model trained on real chemical data from an autonomous lab. Rapid discovery of an extractant built and optimized for USA Rare Earth’s flowsheets could improve our capital and operating efficiency by reducing stage count, equipment needs and raw material consumption, while lowering the carbon footprint and environmental impact of our facilities. Breakthroughs like these are what could help make a Western rare earth value chain possible and accelerate our journey to being competitive on the world stage.”

Pasqal and Riven will tailor their work to USA Rare Earth’s feedstocks, expected to include the Round Top mine in Sierra Blanca, Texas, as well as third-party mixed rare earth carbonates (MREC) and recycled cuttings (known as swarf) from the magnet manufacturing process. Targeting these key feedstocks means the experimental work can potentially impact all aspects of USA Rare Earth’s materials processing work.

“This partnership brings together three companies working at the forefront of technologies that are increasingly important to economic growth, industrial competitiveness and national resilience,” said Wasiq Bokhari, Chief Executive Officer of Pasqal. “Rare earth materials are essential and improving how they are processed has implications far beyond a single industry. By combining Pasqal’s quantum computing capabilities with USA Rare Earth’s materials expertise and Riven’s advanced automation platform, we have an opportunity to accelerate innovation while demonstrating how French and American companies can work together to strengthen critical supply chains.”

USA Rare Earth, Pasqal, and Riven believe this initial machine learning project could create opportunities for a deeper, extended collaboration. Over time, the companies envision a first-of-a-kind, end-to-end extractant discovery process: a quantum machine learning model identifies high-potential extractants, those extractants are tested in Riven’s self-driving lab, and top candidates are validated in USA Rare Earth’s R&D facility in Wheat Ridge, Colorado before being integrated in USA Rare Earth’s flowsheets.

“AI and autonomous labs are the next frontier in critical mineral processing,” said Dr. Orion Archer Cohen, CTO and co-founder of Riven Systems. “We applaud USA Rare Earth’s proactive adoption of these technologies, which forge a path to significant improvements over legacy chemistry. This is exactly how the West can leverage its lead in advanced compute technologies to reindustrialize faster.”

About USA Rare Earth, Inc.
USA Rare Earth, Inc. (Nasdaq: USAR) is building a fully integrated rare earth and permanent magnet value chain across the United States, Brazil and the United Kingdom. Through its ownership of Less Common Metals (LCM), one of the world’s leading producers of rare earth metals and alloys, its development of magnet manufacturing capacity in Stillwater, Oklahoma, the Pela Ema mine in Brazil and the Round Top deposit in Texas, USA Rare Earth operates across the entire value chain from mining to metal-making, alloy production and neodymium magnet manufacturing. USA Rare Earth is establishing a secure, Western-aligned supply of materials essential to the aerospace and defense, semiconductor, energy, data center, physical AI, mobility, healthcare and industrial sectors. For more information, visit www.usare.com.

About Pasqal
Pasqal (Nasdaq: PSQL) helps organizations tackle problems that are difficult or impossible to solve with conventional computing methods alone. Founded in 2019 on Nobel Prize–winning research, Pasqal builds and operates neutral-atom quantum computers, delivered with a full software stack, for industry, science, and governments. Pasqal’s production-ready systems are available both on-premises and through the cloud, enabling organizations to harness quantum computing without requiring in-house quantum expertise. A single hardware platform supports analog workloads today and is designed to evolve toward fault-tolerant quantum computing in the future. 

Headquartered in France with operations globally, Pasqal’s quantum computing systems are used by customers across energy, financial services and advanced materials to address complex challenges. Pasqal’s customers include Saudi Aramco, Crédit Agricole CIB, LG Electronics and supported by partnerships with NVIDIA and IBM (Pasqal is part of the IBM Quantum Network).

About Riven Systems
Riven Systems builds chemical intelligence for industrial independence, with the immediate goal of leveraging AI and automation to bring critical minerals processing back to the West. The company is headquartered in New York City, NY. Learn more at rivensystems.ai.

Contacts
For USA Rare Earth:
Investor Relations Contact
J.B. Lowe, CFA
USA Rare Earth, Inc.
ir@usare.com

Media Relations Contact
Collected Strategies
Dan Moore / Scott Bisang
USAR-CS@collectedstrategies.com

For Pasqal:
Investors
investors@pasqal.com
Media
pr@pasqal.com

For Riven:
Investors
contact@rivensystems.ai
Press
media@rivensystems.ai

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include those relating to the strategic partnership between USA Rare Earth, Pasqal and Riven as well as its mission, goals and planned methodology as well as the expected contribution of each party, the ability of quantum computing, AI and autonomous labs to be successfully applied to industrial applications, including to reduce the cost, energy use and complexity of rare earth processing; the anticipated implications, benefits and applications of any new separation molecules identified by the strategic partnership, the expected impact of any future extractant discovery process resulting from the strategic partnership on USA Rare Earth’s materials processing work and the rare earth value chain and other statements regarding USA Rare Earth’s and Pasqal’s expectations for future development, operations, strategies, transactions and financial performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. Words such as “aim,” “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “growth,” “intend,” “may,” “might,” “plan,” “potential,” “project,” “propose,” “should,” “target,” “vision,” “will,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.

Forward-looking statements are subject to risks and uncertainties and potentially inaccurate assumptions that could cause actual results to differ materially from USA Rare Earth’s and Pasqal’s expectations, including without limitation: risks that the strategic partnership between USA Rare Earth, Pasqal and RIVEN may not yield viable molecule candidates on a timely basis or at all; risks that USA Rare Earth and Pasqal may not realize any of the anticipated benefits associated with the strategic partnership even if viable molecule candidates are identified; the risk that the application of quantum computing, AI and autonomous labs to industrial applications, such as advancing separation chemistry in rare earth processing, is novel and relatively untested; risks that USA Rare Earth may not realize the anticipated benefits of its combination with Serra Verde or its proposed and prior acquisitions, including expected synergies, financial performance, estimated earnings before interest, taxes, depreciation and amortization and, in the case of Serra Verde, integration of operations, on the anticipated timeline or at all; potential delays in the optimization and commissioning program and the Phase II expansion at the Pela Ema facility; political, economic, regulatory, tax, currency and other risks associated with Serra Verde’s operations in Brazil and Switzerland; physical climate risks related to the Pela Ema mine; the assumption of the Offtake Agreement and substantial indebtedness under Serra Verde’s Retained Finance Agreement, in each case which contains restrictive covenants and other requirements that could adversely affect the combined company’s financial flexibility and operations; risks that the Offtake Agreement is terminated or ceases to be in full force and effect or that the counterparty to the Offtake Agreement is insufficiently capitalized, including as a result of a failure to finalize definitive debt financing arrangements within the timeframes contemplated by the Offtake Agreement; risks that the proposed transaction with Carester SAS may not be consummated on its anticipated timeline or at all; the ability of USA Rare Earth’s Stillwater magnet manufacturing facility to generate revenue and the ability of USA Rare Earth’s planned Blacksburg facility to commence commercial operations on the timing and with the production capacity anticipated or at all; USA Rare Earth’s limited operating history; USA Rare Earth’s ability to commercially extract minerals from the Round Top deposit on its anticipated timeline or at all; differences between planned and actual recovery and yield rates; risks that USA Rare Earth may experience delays, unforeseen expenses, increased capital costs, and other complications while developing its projects; USA Rare Earth’s ability to raise necessary capital on acceptable terms or at all; potential dilution to existing stockholders and adverse effect on USA Rare Earth’s stock price if it issues additional common stock or equity-linked securities; the volatility of USA Rare Earth’s stock price; the availability of rare earth oxide, metal feedstock and other materials, utilities (including power and water) and equipment in quantities and prices that allow USA Rare Earth to develop and commercially operate its Stillwater facility and other facilities; USA Rare Earth’s ability to meet individual customer specifications and produce a consistently high quality product; potential supply chain, logistics or product delivery disruptions; any delays in obtaining or renewing permits and licenses; any changes in royalty rates or the imposition of new royalties; risks associated with community relations; fluctuations in demand for and prices of neo magnets, rare earth elements and USA Rare Earth’s other products, including without limitation as a result of dumping, predatory pricing and other tactics by USA Rare Earth’s competitors or state actors or the overall competitive environment; USA Rare Earth’s ability to achieve positive cash flow or profitability or the ability to access cash flow within its corporate structure due to restrictions contained in its financing agreements; USA Rare Earth’s ability to convert current commercial discussions and/or memorandums of understanding with customers for the sale of its neo magnets and other products into definitive orders; USA Rare Earth’s dependence, in part, on the growth of existing and emerging uses for neo magnets; the risk that additional manufacturing, refining and mining competitors could result in a reduction in revenue; geopolitical developments or disruptions, such as changes in the political environment, export/import or environmental policy of the People’s Republic of China, the United States or other countries in which USA Rare Earth operates or sells products or otherwise; USA Rare Earth’s designation on an export control list by China which has had and is expected to continue to have an adverse impact on its ability to source key raw materials and supplies from China; war, terrorism, natural disasters or public health emergencies; USA Rare Earth’s ability to retain or recruit key personnel; environmental, health and safety regulations; the receipt of funding from the U.S. Department of Commerce is subject to the achievement of milestones which may not be achieved on the expected timeline or at all; USA Rare Earth’s ability to comply with requirements for federal, state and local government incentives and financing; the risk from Pasqal pursuing an emerging technology, facing significant technical challenges and the potential that it may not achieve commercialization or market acceptance; Pasqal’s reliance on strategic partners and other third parties; risks related to Pasqal’s indebtedness; and Pasqal’s ability to maintain, protect and defend its intellectual property rights

Additional risks and detailed information regarding factors that may cause actual results to differ materially has been and will be included in USA Rare Earth’s and Pasqal’s filings with the SEC, including USA Rare Earth’s most recently filed Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q and subsequent filings, as well as Pasqal’s recently filed Registration Statement on Form F-1. Any forward-looking statements speak only as of the date of this press release (or such other date as is specified in such statements), and USA Rare Earth and Pasqal undertake no obligation to update any forward-looking statements as a result of new information or future events or developments.

• Resubmission supported by positive topline human factors and pharmacokinetic (PK) study results announced in August 2026
• FDA will determine the resubmission classification and establish the applicable review timeline following its initial review of the resubmission

WARREN, N.J., Sept. 17, 2026 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, today announced that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Anaphylm™ (dibutepinephrine) sublingual film for the treatment of Type I allergic reactions, including anaphylaxis.

“This resubmission reflects the rigor of our response to the FDA’s Complete Response Letter, and we believe it addresses the items identified by the FDA in the Complete Response Letter,” said Daniel Barber, President and Chief Executive Officer of Aquestive Therapeutics. “The completed studies generated human factors, pharmacokinetic, and pharmacodynamic data supporting the revised packaging design and instructions for use, including reducing median pouch-opening time from 17 seconds to 3 seconds. Our conviction in Anaphylm’s potential has never been stronger. As we prepare for a focused, allergist-first launch, if approved, we are moving with urgency to bring Anaphylm to the patients who need it most.”

“When a patient experiences an anaphylactic reaction, rapid access to and administration of epinephrine are critically important,” said David B.K. Golden, M.D.C.M., lead author of the 2023 Anaphylaxis Practice Parameter and a member of Aquestive’s Scientific Advisory Board. “A small, highly portable and needle-free treatment option has the potential to address important barriers associated with carrying and administering epinephrine. Importantly, Anaphylm has previously demonstrated a rapid onset together with robust increases in heart rate and blood pressure; these pharmacodynamic responses were comparable to or greater than those observed with auto-injectors and manual IM epinephrine in clinical studies. Taken together, these characteristics suggest that Anaphylm, if approved, could represent a meaningful advancement in the treatment of severe allergic reactions, including anaphylaxis.”

The Company’s original NDA for Anaphylm was submitted in March 2025. The FDA issued a Complete Response Letter (CRL) on January 30, 2026, which requested that the Company complete a human factors study addressing packaging and administration, and a confirmatory pharmacokinetic (PK) study of Anaphylm. Following receipt of the CRL, Aquestive held a Type A meeting with the FDA to discuss the Company’s proposed approach to addressing the matters identified in the CRL.

In response to the CRL, Aquestive completed a human factors study evaluating revised packaging that incorporated modifications to the pouch opening, instructions for use, and pouch and carton labeling. The Company also completed a confirmatory PK study in healthy volunteers using the revised packaging and revised instructions for use, which evaluated self-administration and clinician administration of Anaphylm and included manual intramuscular epinephrine as a comparator. No protocol-defined use errors were observed in the self-administration arm of the PK study.

About Anaphylm™ (dibutepinephrine) Sublingual Film

Anaphylm™ (dibutepinephrine) sublingual film is a polymer matrix-based epinephrine prodrug investigational product. Anaphylm is similar in size to a postage stamp, weighs less than an ounce, and begins to dissolve on contact. No water or swallowing is required for administration. The primary packaging for Anaphylm is thinner and smaller than an average credit card, can be carried in a pocket, and is designed to withstand weather excursions such as exposure to rain and/or sunlight. The Anaphylm trade name for AQST-109 has been conditionally approved by the FDA. Final approval of the Anaphylm proprietary name is conditioned on FDA approval of the product candidate.

About Aquestive

Aquestive is a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies. The worldwide leader in delivering trusted, quality medications on oral film, Aquestive operates as both a developer of its own proprietary products and a Contract Development and Manufacturing Organization (CDMO) for licensees, with its headquarters in New Jersey and U.S.-based manufacturing facilities in Indiana. The Company is the exclusive manufacturer of four commercialized products marketed by its licensees across six continents using proprietary, best-in-class technologies like PharmFilm^®. Aquestive’s AdrenaVerse™ platform contains a library of more than 20 epinephrine prodrugs enabling the pursuit of various potential allergy and dermatological indications. The Company is advancing Anaphylm™ (dibutepinephrine) sublingual film for the treatment of Type I allergic reactions, including anaphylaxis, and AQST-108 (epinephrine) topical gel for various potential dermatological conditions. For more information, visit Aquestive.com and follow us on LinkedIn.

Forward-Looking Statement

Certain statements in this press release include “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “anticipate,” “plan,” “expect,” “estimate,” “intend,” “may,” “will,” or the negative of those terms, and similar expressions, are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the advancement and related timing of Anaphylm™ (dibutepinephrine) sublingual film through the FDA regulatory review and approval process; our ability to address the matters identified by the FDA in the Complete Response Letter (“CRL”) dated January 30, 2026; the FDA’s review, classification and timing of our NDA resubmission for Anaphylm; the establishment and timing of any FDA review goal date; the significance, interpretation and sufficiency of the human factors and pharmacokinetic study results and the pharmacokinetic and pharmacodynamic data supporting the NDA resubmission; whether the NDA resubmission adequately addresses the deficiencies identified by the FDA in the CRL; the potential approval of Anaphylm by the FDA; the Company’s commercial launch strategy for Anaphylm, if approved; and other statements that are not historical facts. Such forward-looking statements also include statements regarding anticipated timelines, milestones and guidance relating to regulatory submissions, clinical studies, regulatory interactions, and potential approvals, which are inherently uncertain and subject to change based on regulatory feedback, data sufficiency and other factors outside the Company’s control.

These forward-looking statements are based on our current expectations and beliefs and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risk that the FDA may determine that the NDA resubmission does not constitute a complete response to the CRL; the risk that the FDA may classify the resubmission differently than the Company anticipates, resulting in a longer review period than expected; the risk that the FDA may not establish a review goal date within the timeframe anticipated by the Company; risks that preliminary, topline, interim or summary human factors, pharmacokinetic or pharmacodynamic results may differ from final analyses or may be interpreted differently by regulatory authorities; the possibility that the FDA may disagree with the Company’s interpretation of study results, findings or conclusions, or may request additional information, analyses, human factors studies or clinical studies; risks associated with our ability to address the FDA’s comments on and identified deficiencies in our NDA, including the concerns raised by the FDA in the CRL, and whether the FDA may request further information from us (including additional studies), disagree with our protocols, study designs or findings, or otherwise undertake a lengthy review of our NDA resubmission; the risk that the FDA may consider issues raised in one or more citizen petitions or similar submissions relating to Anaphylm; risks associated with our development activities, including delays or changes to the timing, cost or success of our product development programs and clinical studies for Anaphylm; risks of delays in, or failure to obtain, regulatory approval of Anaphylm; risks related to government shutdowns, reductions in government workforce or other governmental resource constraints that may adversely affect the FDA’s ability to review or act upon regulatory submissions in a timely manner or at all; and other uncertainties affecting the Company described in the “Risk Factors” section and elsewhere in the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with the U.S. Securities and Exchange Commission. Given those uncertainties, you should not place undue reliance on these forward-looking statements, which speak only as of the date made. All subsequent forward-looking statements attributable to the Company or any person acting on its behalf are expressly qualified in their entirety by this cautionary statement. The Company undertakes no obligation to update any forward-looking statement after the date of this press release, whether as a result of new information, future events or otherwise, except as required by applicable law.

PharmFilm® and the Aquestive logo are registered trademarks of Aquestive Therapeutics, Inc. All other registered trademarks referenced herein are the property of their respective owners.

Investor inquiries:
astr partners
Brian Korb
brian.korb@astrpartners.com

NORWOOD, Mass., Sept. 17, 2026 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced the September 18th opening of Thrive Dispensary Columbus, the Company’s 14^th Thrive Dispensary location in five states and its second in Ohio. MariMed also operates Thrive Dispensary Tiffin in the western part of the state.

Thrive Dispensary Columbus, located on the city’s east side at 2025 Brice Road, has transformed a former bank property into a modern retail destination. The unique space features a drive-through window and dedicated curbside parking spots.

The opening of the dispensary is part of the Company’s strategic plan to expand its product and retail brands in high-growth markets. Ohio is among the fastest-growing legal cannabis markets in the country, with July 2026 sales reaching $111 million, up 22 percent year-over-year.

For more information on Thrive Dispensary Columbus, visit www.ThriveDispensaries.com.

For More Information Contact:

Howard Schacter, Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007

Payment of Special Dividend Contingent upon Closing of the Pending Merger Transaction

RICHMOND, Va., Sept. 17, 2026 (GLOBE NEWSWIRE) — Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) (“Indivior”) today announced that its Board of Directors declared a special cash dividend (the “Special Dividend”) in the amount of (i) $8.13 per share of Indivior common stock payable to holders of record of the issued and outstanding Indivior common stock as of October 30, 2026 (the “Special Dividend Record Date”) (such holders, the “Special Dividend Record Holders”) and (ii) $8.13 per share of Indivior common stock underlying Indivior equity awards on the Special Dividend Record Date payable, upon vesting of such equity awards, to the holders of certain Indivior equity awards outstanding as of the Special Dividend Record Date (the “Special Dividend Award Holders”).

Payment of the Special Dividend is subject to and contingent upon the closing of Indivior’s previously announced merger transaction (the “Merger”) with Supernus Pharmaceuticals, Inc. (“Supernus”) which is expected to be consummated on or about November 2, 2026, subject to, among other things, the approval by Indivior stockholders of the issuance of Indivior common stock in connection with the Merger, the adoption of the Merger Agreement by Supernus stockholders and the satisfaction or waiver of all conditions under the Merger Agreement. Indivior will not pay the Special Dividend if the Merger is not completed for any reason. Assuming the Merger is consummated on November 2, 2026, payment of the Special Dividend is anticipated to be made to eligible Special Dividend Record Holders on or about November 6, 2026. Supernus stockholders will not be entitled to receive the Special Dividend with respect to any Indivior common stock received as consideration in the Merger.

About Indivior Pharmaceuticals

As the leader in long-acting injectable treatments for opioid use disorder (OUD), Indivior is singularly focused on delivering evidence-based treatment and advancing understanding of OUD as a chronic but treatable brain disease. For more than 25 years, we have revolutionized the science of addiction medicine, developing treatments that help people move toward long-term recovery with independence and dignity. Building on this heritage, we are ushering in a new era, renewing our commitment to individuals living with OUD and carrying forward what matters most: compassion, integrity, and science. Together – with science, people living with OUD, public health champions, and communities – we are powering recovery and renewing hope. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/Indivior.

Important Additional Information and Where to Find It

In connection with the proposed transaction, Indivior has filed with the SEC on September 11, 2026 a document that serves as a prospectus of Indivior and a joint proxy statement of Indivior and Supernus (the “joint proxy statement/prospectus”). Each party also plans to file other relevant documents with the SEC regarding the proposed transaction. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER RELEVANT DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and securityholders may obtain a free copy of the joint proxy statement/prospectus and other relevant documents filed by Indivior and Supernus with the SEC at the SEC’s website at www.sec.gov. Copies of the documents filed by Indivior with the SEC are available free of charge on Indivior’s website at www.indivior.com or by contacting Indivior’s Investor Relations at InvestorRelations@indivior.com. Copies of the documents filed by Supernus with the SEC are available free of charge on Supernus’ website at www.supernus.com.

No Offer or Solicitation

This communication is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy or exchange any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This communication does not constitute a prospectus or prospectus equivalent document. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Participants in the Solicitation

Indivior and Supernus and their respective directors, executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. Information about directors and executive officers of Indivior is available in the Indivior proxy statement for its 2026 Annual Meeting, which was filed with the SEC on March 27, 2026. Information about directors and executive officers of Supernus is available in the Supernus proxy statement for its 2026 Annual Meeting, which was filed with the SEC on April 30, 2026. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, can be found in the joint proxy statement/prospectus and other relevant materials filed with the SEC regarding the proposed transaction. Investors should read the joint proxy statement/prospectus carefully before making any voting or investment decisions. Investors may obtain free copies of these documents from Indivior and Supernus as indicated above.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and other federal securities laws. From time to time, oral or written forward-looking statements may also be included in other information released to the public. These forward-looking statements are intended to provide Supernus’s and Indivior’s respective management’s current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “project,” “may,” “will,” “would,” “could,” “should,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these words. All forward-looking statements involve risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. These statements, including statements regarding the proposed merger of equals of Supernus and Indivior, the expected timing of the closing, expectations related to Indivior’s payment of the Special Dividend in connection with the closing, and the anticipated benefits and prospects of the combined company, are based on management’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including, among others: the risk that the proposed merger may not be completed in a timely manner or at all; the failure to obtain the required approvals of Supernus’ or Indivior’s stockholders; the failure or delay in obtaining required regulatory approvals, or the imposition of conditions in connection therewith; the failure to satisfy the other conditions to closing; the possibility that a competing or superior acquisition proposal is made; the fact that the exchange ratio is fixed and will not be adjusted for changes in the market price of Supernus or Indivior shares; the effect of the announcement, pendency or completion of the transaction on the market price of Supernus and Indivior shares; the effect of the additional indebtedness incurred to fund the Special Dividend on the combined company; the effects of business disruption resulting from the announcement or pendency of the transaction; the diversion of management’s attention and resources from ongoing business operations; the effect of the transaction on the parties’ ability to retain and hire key personnel and to maintain relationships with customers, suppliers and other business partners; restrictions during the pendency of the transaction that may limit the parties’ ability to pursue business opportunities or strategic transactions; the risk that the anticipated benefits, synergies and cost savings may not be realized within the expected timeframe or at all; the difficulties and costs of integrating the two businesses; significant transaction costs and/or unknown or inestimable liabilities; the risk that the merger does not qualify for its intended treatment as a tax-free reorganization; the occurrence of any event that could give rise to termination of the merger agreement, including in circumstances requiring payment of a termination fee; the risk of stockholder litigation in connection with the transaction; the impact of macroeconomic and market conditions, including economic downturns, international conflict, trade disputes and tariffs; and the other risks identified in Supernus’ and Indivior’s filings with the SEC and in the joint proxy statement/prospectus when it becomes available. There can be no assurance that the proposed merger or the contemplated transactions including the Special Dividend will in fact be consummated in the manner described or at all. These forward-looking statements speak only as of the date of they are made and neither Supernus nor Indivior undertakes any obligation to update any forward-looking statement, except as required by applicable law.

Indivior Pharmaceuticals Contacts

Investors	Jason Thompson	VP, Investor Relations	+1 804 402 7123 jason.thompson@indivior.com
Media	Cassie France-Kelly	VP, Communications	+1 804 594 0836 Indiviormediacontacts@indivior.com

Not for distribution to United States newswire services or for dissemination in the United States.

TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) — Labrador Gold Corp. (TSX.V: LAB | FNR: 2N6) (“LabGold” or the “Company”) is pleased to announce its intention to complete a non-brokered private placement (the “Offering”) for aggregate gross proceeds of a minimum of $2,000,000 and a maximum of $4,000,000. In connection with the Offering, the Company also intends to appoint Raymond D. Harari as President and a director of the Company and to enter into an investor rights agreement with the lead investors, in each case as described below and effective at the closing of the Offering.

The Offering will consist of: (i) common shares of the Company issued on a non-flow-through basis (the “HD Shares”); and (ii) common shares of the Company that will qualify as “flow-through shares” within the meaning of subsection 66(15) of the Income Tax Act (Canada) (the “Tax Act”) (the “FT Shares” and, together with the HD Shares, the “Shares”), each at a price of $0.05 per Share, for the issuance of between 40,000,000 and 80,000,000 Shares.

The Offering is being led by Matachewan Consolidated Mines, Limited (TSX.V: MCM-A) (“Matachewan”) and McChip Resources Inc. (TSX.V: MCS) (“McChip” and, together with Matachewan, the “Lead Investors”), which intend to subscribe for $2,133,790.45 of FT Shares, representing 42,675,809 FT Shares. In connection with the initial closing of the Offering, the Company and the Lead Investors intend to enter into a customary investor rights agreement providing the Lead Investors with the right to nominate two directors to the Board of Directors of the Company along with certain information, participation and top-up rights for so long as the Lead Investors and their permitted transferees collectively hold at least 10% of the issued and outstanding common shares of the Company. The participation and top-up rights are intended to permit the Lead Investors, subject to customary exclusions, applicable law, TSXV acceptance and a maximum ownership level of 19.99% unless any required shareholder approval is obtained, to maintain their collective pro rata ownership percentage in connection with subsequent issuances of securities by the Company. The Shares acquired by the Lead Investors under the Offering will also be subject to a one-year contractual lock-up, subject to customary exceptions. The Lead Investors will also vote the common shares of the Company held by them in favour of the existing board of directors, and the Lead Investors’ nominees, at the next annual meeting. In addition, for a period of two years, they will vote in favour of the election of Roger Moss and Leo Karabelas as directors of the Company.

In connection with, and effective upon, the closing of the Offering, the Company intends to appoint Raymond D. Harari as President and a director of the Company. Mr. Harari will be the Lead Investors’ initial nominee to the board of directors under the investor rights agreement. The Lead Investors will have the right to nominate a second director to the Board of Directors of the Company at the next annual meeting to be held on or before April 30, 2027.

Mr. Harari is the founder of Canalis Capital, a merchant bank focused on the resource sector and currently serves as President of Argentina Metals Corp. (TSX.V: VLLC). He has served as a senior executive and director of a number of publicly listed mineral exploration companies including Hercules Metals Corp., Westward Gold Inc. and Sendero Resources Corp.

“We are pleased to welcome Ray as incoming President and director of Labrador Gold. Based on his prior success in the mineral exploration world and his significant network in Latin America he will be an excellent addition to the LabGold team,” said Roger Moss, CEO of Labrador Gold. “I am excited to work with Ray as we continue to build on our success and create opportunities to grow the Company for the benefit of all our shareholders.”  

“Labrador Gold has a quality shareholder base and, in Roger, a geologist who took the Kingsway property from grassroots to a sale to New Found Gold, which few in this business ever achieve. I’m here to bring the same discipline to the capital markets strategy that he brings to exploration,” said Raymond D. Harari.

The gross proceeds from the sale of the FT Shares will be used to incur eligible “Canadian exploration expenses” that qualify as “flow-through mining expenditures”, as those terms are defined in the Tax Act (the “Qualifying Expenditures”), on the Company’s mineral properties in Canada. The Company will renounce the Qualifying Expenditures in favour of the subscribers of the FT Shares with an effective date no later than the date permitted under the Tax Act, in an aggregate amount not less than the gross proceeds raised from the issuance of the FT Shares. The net proceeds from the sale of the HD Shares will be used for exploration and development activities, working capital and general corporate purposes.

All securities issued under the Offering will be subject to a hold period of four months and one day from the date of issuance in accordance with applicable Canadian securities laws and the policies of the TSX Venture Exchange (the “TSXV”). The Offering is expected to close in one or more tranches on or about September 28, 2026, or such other date or dates as the Company and the Lead Investors may agree, and is subject to customary conditions, including the receipt of all necessary corporate and regulatory approvals, including the acceptance of the TSXV. The Company does not intend to pay finder’s fees in connection with the Offering.

The securities referred to in this news release have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or the securities laws of any state of the United States, and may not be offered or sold in the United States absent registration or an available exemption from the registration requirements of the U.S. Securities Act and applicable securities laws of any state of the United States. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction.

Four insiders of the Company intend to subscribe for 11,700,000 FT Shares for $585,000. The insider private placements are exempt from the valuation and minority shareholder approval requirements of Multilateral Instrument 61-101 (“MI 61-101”) by virtue of the exemptions contained in sections 5.5(a) and 5.7(1) (a) of MI 61-101 in that the fair market value of the consideration for the securities of the Company which will be issued to the insiders will not exceed 25% of its market capitalization.

About Labrador Gold

Labrador Gold is a Canadian-based hybrid mining and investment issuer focused on the acquisition and exploration of prospective mineral projects in Canada and on strategic investments in mining companies and assets that the Company believes have the potential to generate long-term value.

The Mariposa project covers 16,000 ha in the White Gold District and is 40 kilometres southeast of the White Gold Project and 30 kilometres east-northeast of Fuerte’s Coffee gold project. Mariposa shares many geological similarities to both the Golden Saddle (part of the White Gold Project) and Coffee gold deposits including host lithologies, mineralization style and structural control. The property occurs at the headwaters of significant placer gold producing creeks with historic placer production of 73,000 oz from Scroggie Creek (3) indicative of significant bedrock gold mineralization yet to be fully defined. Six significant gold occurrences have been delineated by over 13,000 soil samples to date, including the most advanced Skookum Main and Skookum West prospects.

The Watson Project, a joint venture with Nemo Resources Inc., represents the largest landholding in the Fort Hope Greenstone Belt which is significantly underexplored compared to other greenstone belts (e.g. Red Lake and Pickle Lake) in northwestern Ontario. While the exploration focus will be on gold, the Watson project also hosts significant potential for critical minerals (e.g. antimony, nickel, copper and zinc). The proposed road to the Ring of Fire, expected to begin construction in mid-2026, runs through the Watson property and, once complete, will significantly reduce exploration and development costs.

The Hopedale property covers much of the Archean-age Florence Lake greenstone belt, which extends over 60 kilometers. While typical of greenstone belts globally, the area has been underexplored. LabGold’s work to date has identified gold anomalies in rocks, soils, and lake sediments across a three-kilometer section of the northern portion of the belt. Five gold occurrences lie along this trend, four of which were discovered by LabGold. Additional anomalous gold values occur across approximately 40 kilometers of the southern portion of the belt. Recent exploration has also demonstrated potential for copper, nickel, and cobalt.

The Borden Lake project near Chapleau, Ontario lies immediately southeast of Discovery Silver Corp’s Borden gold mine. Past exploration by LabGold identified two anomalous gold zones based on geochemistry and geophysics.

The Company has 170,809,979 common shares issued and outstanding and trades on the TSX Venture Exchange under the symbol LAB.

For more information, please contact:

Roger Moss, President and CEO

Tel: 416-704-8291

Website: www.labradorgold.com

X: @LabGoldCorp

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains forward-looking statements and forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities laws. Forward-looking statements in this release include, but are not limited to, statements regarding the completion, size, pricing and timing of the Offering; the number and composition of Shares to be issued under the Offering; the participation of the Lead Investors and other subscribers; the anticipated use of the proceeds of the Offering; the Company’s intention to incur and renounce Qualifying Expenditures; the proposed appointment of Raymond D. Harari as President and a director of the Company; the proposed investor rights agreement and one-year contractual lock-up; and the receipt of corporate and TSXV approvals.

Forward-looking statements are based on management’s current expectations, estimates, assumptions and beliefs as of the date of this release, including assumptions regarding the execution of definitive subscription and investor rights documentation; the satisfaction of the conditions to closing; the availability of applicable prospectus exemptions; the receipt of all required corporate and regulatory approvals, including the acceptance of the TSXV; the availability of sufficient subscriber demand; the ability of subscribers to fund their subscriptions; the absence of a material adverse change before closing; the availability of Qualifying Expenditures; and the Company’s ability to incur and renounce the Qualifying Expenditures within the periods required under the Tax Act.

Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those expressed or implied by such statements. These risks and uncertainties include, among others, the risk that the Offering may be delayed, reduced, restructured or not completed on the terms described or at all; that the Company may raise less than the maximum amount contemplated; that subscribers may withdraw or fail to fund their subscriptions; that required corporate or regulatory approvals, including TSXV acceptance, may not be obtained; that the Company and the Lead Investors may not enter into the proposed investor rights agreement or lock-up arrangements; that the proposed appointment of Mr. Harari may not be completed; that sufficient Qualifying Expenditures may not be available; that the Company may not incur or renounce Qualifying Expenditures within the periods required under the Tax Act; and the risks described in the Company’s continuous disclosure filings with Canadian securities regulatory authorities.

Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

Highlights:

• Multiple high-grade gold zones intersected at the BK2 Target within the broader Belmont Prospect at Khorixas.
  • A 3,500 m follow-up drilling plan has been outlined to test multiple targets across the Belmont Prospect, including BK1, BK2, BK8 and Plains.
  • K17 geophysical program set to commence, advancing the district scale intrusion-related copper-gold target toward drill-ready status.
  • Best RC drill hole intersections at the BK2 Target:
    • BKR010
      • 3m @ 9.21 g/t Au from 17m, and
      • 5m @ 0.90 g/t Au from 39m, and
        • 3m @ 6.45 g/t Au from 70m
    • BKR019
      • 1m @ 4.70 g/t Au from 53m, and
      • 5m @ 1.11 g/t Au from 63m, and
      • 7m @ 3.23 g/t Au from 78m

VANCOUVER, British Columbia, Sept. 17, 2026 (GLOBE NEWSWIRE) — Ongwe Minerals Inc. (TSXV: OGW) (NSX:ONG) (“Ongwe” or “the Company”) is pleased to announce that it has intersected multiple high-grade gold zones at it BK2 Target within the Belmont Prospect at its Khorixas Gold Project, Namibia.

The Belmont Prospect, part of the Khorixas Gold Project, is a large-scale, 12 × 6 km greenfields surface gold discovery made by Ongwe. It comprises 19 individual gold anomalies, including BK2, defined through soil, calcrete, rock-chip and bedrock sampling. Most of the prospect is covered by up to 15 m of calcrete, adding complexity to the exploration program. Recent drilling, including the results reported in this press release, indicates that Belmont has the potential to host multiple high-grade deposits within its existing gold footprint. The mineralization style is comparable to that of Osino Resources’ Eureka gold discovery, located 50 km east of Belmont.

Dave Underwood, Ongwe’s CEO commented: “The recent RC scout drilling at the Belmont BK2 target has confirmed that there is high-grade gold associated with complex folding and a late-stage influx of sulphides including pyrrhotite, pyrite and arsenopyrite. The initial intersections at BK2 are narrow, but the grades are very encouraging including 7m @ 3.23g/t in hole BKR019 and 3m @ 9.61g/t and 3m @ 6.45g/t in hole BKR010.

This mineralization looks similar to Osino’s high-grade Eureka deposit 50km to the east which consists of a series of sulphide dominated plunging shoots controlled by complex folding. The Belmont mineralization footprint is substantially bigger than Eureka and we believe there could be multiple Eureka style deposits hiding beneath the calcrete cover. Given the structural complexity of these types of deposits, the next phase of drilling will be with a diamond rig so that we can start understanding the structural and lithological controls of the mineralization. The BK8 target is also a very compelling undrilled target with a wide surface gold footprint over 1.5km in length and soil samples as high as 1.49 g/t Au.

These encouraging results further strengthen our belief that our licence portfolio contains multiple prospective targets, each with the potential to host commercial deposits.”

Underwood continued: “We are also ramping up activity at the K17 prospect with two phases of geophysics designed to produce copper-gold intrusion related drill targets for testing in the second quarter of 2027. The Phase 1 deep looking MT and gravity program kicks off in October and should take about two months to complete.”

Figure 1: Map showing the outline of the Khorixas Gold Project along with the location of the Belmont and K17 Prospects. Map also shows the location of the Eureka Gold Deposit (Osino, released 9 August 2023) and the Ondundu Gold Deposit (Osino, released on 27 October 2022, 26 Mt at 1,13 g/t Au inferred)

Belmont Prospect

Earlier this year, the Company commenced a reverse circulation (RC) bedrock sampling program to test in situ mineralization beneath gold anomalies defined by surface calcrete sampling. The program led to the discovery of the Plains Anomaly, a 2 km-long in situ gold anomaly located along the KGT basin-margin fault zone – see Figure 2. The bedrock sampling program was subsequently extended to several other targets within the Belmont Prospect. However, it quickly became evident that the style of mineralization on or near the KGT basin-margin fault differed from that associated with splay structures away from the main fault.

Mineralization along the main KGT basin-margin fault appears to be associated with disseminated sulphides within broader alteration zones. By contrast, mineralization within splay structures away from the main fault appears to be associated with high-grade, brecciated quartz veins containing semi-massive pyrrhotite, pyrite and arsenopyrite. This interpretation led to a redesign of the bedrock sampling campaign to include shallow RC fence lines across three splay targets: BK2, BK7 and BK13 – see Figure 2.

Figure 2: Heat map of gold-in-soil and gold-in-calcrete across the Belmont Prospect. The map also shows the layout of the various Targets within the Belmont Prospect, highlighting the targets earmarked for drilling in 2026.

BK2 Drilling

A total of 20 RC holes, comprising 1,979 m, were drilled across the BK2, BK7 and BK13 targets. The holes were drilled at an inclination of 60 degrees and had an average inclined depth of 100 m. Of the 20 holes drilled, only two, BKR010 and BKR019, intersected significant gold mineralization – see Figure 4. These results, together with limited diamond drilling (DD) at the Belmont Prospect, indicate that the gold systems are structurally controlled and underscore the importance of understanding these controls to trace the mineralized zones.

Hole BKR010 was drilled approximately 120 m south-southeast of the previously drilled holes BKP036 and BKDD003 – see Figure 3. Given the extensive calcrete cover in the immediate vicinity and the absence of structural data, the strike of the mineralization intersected by the earlier drilling was unclear. BKR010 therefore formed part of a fence line designed to test the strike of the mineralization. The hole intersected a sequence of chlorite schists and arkosic sandstones. Mineralization occurred in several quartz-sulphide zones containing pyrrhotite, pyrite and arsenopyrite, concentrated along contacts between the more competent arkosic sandstone and the less competent schist.

Hole BKR019 was drilled between the previously drilled holes and BKR010 – see Figure 3. The hole was designed to test the continuity of mineralization between BKP036 and BKDD003 to the north and BKR010 to the south. As in the other holes, mineralization occurred in several quartz-sulphide zones containing pyrrhotite, pyrite and arsenopyrite, concentrated along contacts between the more competent arkosic sandstone and the less competent schist. BKR019 confirmed that the mineralization strikes north-northwest and is controlled, at least in part, by bedding and likely folding.

Figure 3: Plan view showing the reported drill holes, BKR010 and BKR019 within the BK2 Target. The interpreted mineralized zone is highlighted in yellow. Reported drill intervals has a lower cut-off grade of 0.3 g/t Au and contain no more than 3m of internal waste.

Figure 4: Long section through the mineralized zone showing the down hole results of the reported holes, BKR010 and BKR019. The figure also shows the previously reported results of holes BKP036 (percussion) and BKDD003 (diamond).

Belmont Exploration Strategy

Recent drilling has demonstrated the potential of the Belmont gold system. The Company believes the Belmont Prospect has the potential to host multiple high-grade orebodies comparable to Osino Resources’ Eureka gold deposit located 50km to the east. The Company has finalized its exploration strategy for the remainder of 2026, comprising 2,000 m of RC drilling and 1,500 m of DD drilling. Drilling will focus on the following targets:

• BK1 – testing the down-dip extension of the previously reported percussion-drilling intersection of 50 m at 0.1 g/t Au.
• BK2 – testing the northern and southern extensions and potential parallel zones.
• BK8 – initial drill testing of the 1.5 km-long, high-grade soil anomaly, with values of up to 1.49 g/t Au.
• Plains – initial drill testing of the 2 km-long bedrock anomaly.

K17 Prospect

The Company has integrated independent reviews from GeoAqua Consultants Limited and Geokincern Pty Ltd to refine the genetic and structural models for the K17 copper-gold prospect at the Khorixas Project.

Geochemical analysis outlines a broad, 8-by-7-kilometer mineralized footprint. This area is characterized by a core copper-gold-zinc-calcium-manganese anomaly, framed by distal halos of arsenic, bismuth, lead, and molybdenum. This distinct signature, combined with the presence of granodiorite xenoliths, strongly suggests that a hidden intermediate-to-felsic intrusion is driving the hydrothermal system. Country wide gravity data along with broad spaced regional MT data collected in 2024 supports this model: immediately southwest of the prospect, a sub-circular gravity high and associated magnetic gradients are hypothesized to represent the buried intrusive body or a skarn-style alteration complex. Adding further weight to this target, higher-grade surface copper and gold samples cluster directly around the margins of a prominent resistive core – see Figure 6.

To prioritize drill targets across the K17 system, the Company will execute a two-phased geophysical program. In October and November 2026, the Company plans to conduct a mineral system scale AMT and ground gravity survey at 1-kilometer station spacing to define the deeper sources of the MT and gravity anomalies visible in regional data – see Figure 5. This work will be followed up by a detailed Induced Polarization (IP) program in the first quarter of 2027, aimed at targeting blind, disseminated sulfide zones similar to the surface exposures at K17 central. This systematic approach reflects the Company’s view that K17 is the primary window into an expansive, district-scale mineral system capable of hosting multiple deposit-scale targets.

Figure 5: Map showing the proposed mineral system scale AMT and Gravity survey area (blue polygon), with the K17 Central resistivity anomaly and major structures highlighted.

Figure 6: Conductivity map from the 2024 regional MT survey showing the K17 Central resistivity anomaly in relation to high-grade grab samples – highlighting the link between surface geochemistry and subsurface geophysical anomalies.

Assay Method

The Company utilized the detectORE^™ analytical technique, designed to enable the measurement of trace gold concentrations in geological samples using a portable X-Ray Fluorescence (pXRF) instrument. This process overcomes the traditional limitations of gold analysis by pXRF including low gold concentrations and metal peak interference. The method involves leaching 250g of sieved material in a sealed pouch with 500ml of GLIX-20^™ lixiviant and a Collector Device (CD). Following a 16-hour tumble in a Maxi Mixer barrel to dissolve the gold, the CD is removed, rinsed, and analyzed for 150 seconds using detectORE^™ mode firmware. This partial analysis technique is managed through pLIMS^™ software with strict QAQC protocols to identify relative gold anomalism. The detectORE^™ gold technique is designed for rapid on-site assessment and is not used for the formal quantification of gold content or the estimation of Mineral Resources. An extensive orientation program was carried out before putting the detectORE^™ methodology into production by comparing soil, calcrete and rock chip sample assays with Aqua Regia and FireICP. The detectORE^™ system performed extremely well and identified the same anomalies as the laboratory techniques in all conditions.

As part of the current exploration program, all RC drill samples undergo an initial in-house analysis using the detectORE^™ technique. Any samples returning a value equal to or greater than 20 detectable Units (dU) are prioritized for formal verification via Fire Assay at the MSALAB facility in Omaruru, Namibia, or via Photon Assay at the Gloriosa facility in Otjiwarongo, Namibia. The Fire Assay procedure involves drying and splitting the sample to 1kg, followed by crushing to 2mm. A 250g sub-sample is then pulverized to 85% passing 75 microns, from which a final 50g aliquot is taken for Fire Assay with an Atomic Absorption (AA) finish. For Photon Assay, the prepared sample is split to approximately 500 g and loaded into a barcoded, labelled plastic jar. The sealed sample is irradiated with high-energy X-rays, which excite gold nuclei; as the nuclei return to a stable state, they emit gamma rays at characteristic energies. Detectors measure these emissions and the instrument calculates the gold concentration across the bulk sample. The analysis is non-destructive and is conducted using a four-cycle protocol, providing a stated gold detection limit of 20 ppb.

The reported results for holes BKR010 and BKR019 were obtained using the Photon Assay technique.

QA/QC

All of Ongwe’s sample assay results have been independently monitored through a quality assurance and quality control (“QA/QC”) program including the insertion of blind standards, blanks, and field duplicate samples. The Company maintains rigorous monitoring for both in-house and laboratory analyses to ensure data reliability. For the detectORE^™ process, which provides rapid on-site assessment of gold anomalism, a Certified Reference Material (CRM) sample is inserted every 15 samples to monitor the performance of the pXRF instrument and the leaching efficiency. For the formal fire assay verification conducted at MSALABS, or Photon Assay conducted at Gloriosa, a CRM is inserted every 30 samples. This MSALABS laboratory procedure involves precise pulverization and a 50g fire assay with an Atomic Absorption (AA) finish to provide formal quantification for prioritized drill samples. At Gloriosa, the sample is systematically split to approximately 500 g, sealed in a barcoded jar and analyzed using a four-cycle Photon Assay protocol. Each cycle irradiates the bulk sample with high-energy X-rays and measures the characteristic gamma-ray emissions generated by activated gold nuclei; the measurements are combined to improve analytical precision.

Data Verification

Carl Joone, BSc. (Hons), the President and Co-Founder of Ongwe Minerals Inc., and a Qualified Person for the purposes of National Instrument 43-101, has verified all the data disclosed, including a review of the sampling procedures, chain of custody, and assay results underlying the disclosure, by plotting and verifying against raw data received. Mr. Joone noted no errors or omissions during the data verification process.
Qualified Person

Carl Joone, BSc. (Hons) is the President and Co-Founder of Ongwe Minerals Inc. and is a registered Professional Natural Scientist with the South African Council for Natural Scientific Professions (Pr. Sci. Nat. No. 172695) and a Qualified Person for the purposes of National Instrument 43-101. Mr. Joone has reviewed and approved the scientific and technical information in this news release.

About Ongwe Minerals Inc.

Ongwe Minerals Inc. is a Canadian listed gold exploration company focused on the discovery and advancement of new gold systems in Namibia. The Ongwe team, previously with Osino Resources (sold to Shanjin International), has a history of making and advancing gold discoveries in Namibia, including Osino’s Twin Hills (currently in construction) and Eureka deposits, and the advancement and sale of Auryx Gold’s Otjikoto gold deposit (in production, sold to B2Gold).
The Company’s current focus is on three promising gold projects in the emerging Northwest Damara gold belt in Namibia, with a focus on the Omatjete and Khorixas Gold Projects.
The Omatjete Gold Project is strategically located along the regional Okondeka Fault Zone, which also hosts the Kokoseb gold deposit (WIA Gold). Early surface work by Ongwe led to the discovery of the Manga Gold Prospect which has a 4.5km x 1km footprint of gold in soil and early scout drilling indicating gold in bedrock. Recent regional sampling in 2026 has led to the discovery of the large scale, high tenor Nguni anomaly 17km east of Manga. Nguni currently has a strike length of 6km and is open to the west, north and east. The Omatjete Project still has significant growth potential and work is ongoing to define further anomalies along the Okondeka Fault system.
The Khorixas Gold Project is situated just 50km west of Osino’s Eureka gold project, adjacent to the northern margin of the Damara Orogenic Belt. Khorixas hosts two large-scale surface discoveries called Belmont and K17. The Belmont prospect has a surface gold footprint of approximately 12 × 6km and lies between the regional scale, basin margin, Khorixas Fault and the Belmont Thrust Zone. Calcrete and grab sampling to date have indicated eighteen target areas.

ON BEHALF OF THE BOARD OF DIRECTORS
“Dave Underwood”
Chief Executive Officer

CONTACT INFORMATION
Ongwe Minerals Inc.	Ongwe Minerals Inc.
Dave Underwood, Chief Executive Officer	Carl Joone, President & Co-Founder
Email: dave@ongweminerals.com	Email: carl@ongweminerals.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Cautionary Statements Regarding Forward Looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the use of proceeds from the Company’s future plans or prospects of the Company, including prospects for discovery of mineral resources or the results of future exploration programs. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking statements are necessarily based upon a number of assumptions that, while considered reasonable by management, are inherently subject to business, market and economic risks, uncertainties and contingencies that may cause actual results, performance or achievements to be materially different from those expressed or implied by forward-looking statements. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Other factors which could materially affect such forward-looking information are described in the risk factors in the Company’s most recent annual management’s discussion and analysis which is available on the Company’s profile on SEDAR+ at www.sedarplus.ca. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/9c1c3c43-a63a-4b42-b25d-8900d5dcb36d

https://www.globenewswire.com/NewsRoom/AttachmentNg/4678d4bd-f3c4-4f3f-9d93-5b76b0ed2f79

https://www.globenewswire.com/NewsRoom/AttachmentNg/9863d226-f6bd-4753-8b70-072f40c940a0

https://www.globenewswire.com/NewsRoom/AttachmentNg/17f52c10-4a1b-46ad-9070-3616046f6d22

https://www.globenewswire.com/NewsRoom/AttachmentNg/30f96630-d74f-4607-abba-2467951a4246

https://www.globenewswire.com/NewsRoom/AttachmentNg/41ca7506-e50f-4966-a8d1-538be568a286

MONTREAL, Sept. 17, 2026 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; FRANKFURT:1XQ; “BRW” or the “Company”) is pleased to report the results of a drill hole that represents an exceptional and material expansion to the Anais dyke at the Anatacau Main Project, located 20 km east of Rio Tinto’s Galaxy project, in the Eeyou Istchee James Bay region of Quebec. This hole is part of the 2026 summer drill campaign, which is still ongoing at the Anatacau Main Project.

Significant Highlights of Drill Hole AN-26-15:

• The hole’s intercept of 202 metres of spodumene-bearing pegmatites containing, on average, an estimated 25% spodumene extends the Anais dyke to a vertical depth of 300 metres.
• This represents the single largest pegmatitic intercept drilled by Brunswick Exploration across its portfolio and is one of the largest mineralized intercepts reported in the James Bay amongst lithium focused companies.
• The Anais dyke remains open in all directions and is significantly expanded following this drill hole. At this time, BRW believes there is considerable potential to continue expanding this discovery.
• The drill hole also encountered several other spodumene-bearing pegmatite intervals, separate from the 202-metre intercept, with widths of up to 21.3 metres, containing between 20–35% spodumene.
• Assays are pending and will be released as quickly as possible.

The Anatacau Project is strategically located approximately 440km north of Matagami by road, whereas PMET Resources’ Shaakichiuwaanaan project is 840km away, and WhiteRock’s Banana project is 1,060km away.

Mr. Killian Charles, President and CEO of BRW, commented: “While it is atypical for us to release mineralized intervals without assays, we believe the size of this major interval and its implication for the Anatacau Main project is highly material to Brunswick Exploration shareholders as it instantly elevates the Anais dyke to being one of the most exciting discoveries globally. Importantly, this discovery remains open in all directions. We are actively drilling at Anatacau and look forward to expanding this discovery. More details from future work programs at Anatacau will be shared shortly.”

Mr. Charles continued: “Of note, we will be also releasing exciting assays from Mirage in the coming weeks. It is once more an affirmation of our strong exploration focus as we continue to expand our portfolio. Brunswick Exploration has now made two sizeable discoveries, Mirage and Anatacau, and sees more opportunity in Greenland, the Middle East and further abroad.”

Figure 1: Surface Map of the Anatacau Main Project and Drill Holes Completed

Figure 2: Cross Section A-A’ (see Figure 1 for Location)

Figure 3: Regional Map of the Anatacau Main and Anatacau West Projects

Figure 4: Representative Core Photo (320 to 382 meters)

Discussion of Results

To date, a total of two holes totaling approximately 800 metres have been drilled in the Anais sector, with all assay results pending.

Hole AN-26-15 targeted the Anais Main dyke in a large, down-dip, 130 meter step-out and returned three major pegmatitic intervals, 8.35 metres, 21.50 metres and 202.45 metres, confirming the Anais Main dyke to a vertical depth of 300 metres. This 202-metre intercept also confirms that the dykes at Anatacau significantly increase in size at depth, where it remains highly mineralized, with up to 35% fine to coarse grained spodumene crystals. Visual mineralization over the whole interval is estimated at approximately 25% and the dykes are hosted in mafic volcanic unit. This new interpretation of thickening mineralized dykes at depth is also reflected in the relationship between holes AN-26-09 (36 metres at 1.08% Li₂O) and AN-26-10 (9.9 metres at 0.58% Li₂O and 8 metres at 0.59% Li₂O) (press release of May 11, 2026).

Hole AN-26-15 also extends the Anais Main dyke footprint to the west, which is now traced over 650 by 350 metres and remains open in all directions.

The thickening of the pegmatitic intrusions at depth will be tested by hole AN-26-16 (in progress), which is targeting the down-dip extension of the dykes intercepted in AN-26-08 (123 metres at 0.72% Li₂O; press release of May 11, 2026, Figure 2).

Table 1: Best LCT Pegmatite Intervals

Hole ID	From (m)	To (m)	Length (m)
AN-26-15	171.65	180.00	8.35
	Total length		8.35
	211.40	232.90	21.50
	Total length		21.50
	274.25	282.30	8.05
	284.55	292.60	8.05
	298.40	395.35	96.95
	397.50	402.40	4.90
	408.55	421.40	12.85
	424.90	427.80	2.90
	433.00	450.40	17.40
	454.80	463.70	8.90
	470.40	476.70	6.30
	Total length		202.45

*The true thickness of the Anais dyke is estimated to be approximately 75%
**Interval total may contain up to 25% country rocks

Table 2: Drill Hole Collars (UTM Nad83, Zone 18N)

Drill Holes	Azimuth	Dip	Length (m)	UTM X	UTM Y	Elevation (m)
AN-26-14	100	47	295	380333	5784464	207
AN-26-15	125	52	498	380198	5784693	198
AN-26-16	95	58	In progress	380394	5784538	200

Note

SEC Technical Report Summary for the James Bay Lithium Project prepared by SLR Consulting (Canada), Wave International Pty and WSP Canada for Arcadium Lithium Plc., dated August 31 2023.

QAQC

All drill core samples were collected under the supervision of BRW employees and services contractor Explo-Logik, applying industry-standard QA/QC procedures to its drilling and prospecting programs. All sample preparation and analytical work will be performed by Agat Laboratories. Samples will be prepared with methods 200075 and 200087 and dissolved in a sodium peroxide solution, prior to multielement analysis by ICP-OES and ICP-MS according to the Agat method 201378.

Qualified Person

The scientific and technical information contained in this press release has been reviewed and approved by Mr. Simon T. Hébert, VP Development. He is a Professional Geologist registered in Quebec and is a Qualified Person as defined by National Instrument 43-101.

About Brunswick Exploration

Brunswick Exploration is a Montreal-based mineral exploration company listed on the TSX-V under symbol BRW. The Company is focused on grassroots exploration for lithium in Canada, a critical metal necessary to global decarbonization and energy transition. The company is rapidly advancing the most extensive grassroots lithium property portfolio in Canada, Greenland and Saudi Arabia underpinned by its Mirage project, one of the largest undeveloped hard-rock lithium Inferred Mineral Resource Estimate in the Americas, with 52.2Mt grading 1.08% Li2O.

Investor Relations/information
Mr. Killian Charles, President and CEO (info@BRWexplo.com)
Contact number: 514 861 4441

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

Cautionary Statement on Forward-Looking Information

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation based on expectations, estimates and projections as at the date of this news release. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, delays in obtaining or failures to obtain required governmental, environmental or other project approvals; uncertainties relating to the availability and costs of financing needed in the future; changes in equity markets; inflation; fluctuations in commodity prices; delays in the development of projects; the other risks involved in the mineral exploration and development industry; and those risks set out in the Corporation’s public documents filed on SEDAR at www.sedar.com. Although the Corporation believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Corporation disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

A photo accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/faa6d3d0-bd5c-45a9-b9e4-0a01beec6896
https://www.globenewswire.com/NewsRoom/AttachmentNg/18537c1c-bb3a-4618-adda-e1a398072a04
https://www.globenewswire.com/NewsRoom/AttachmentNg/c2400072-144d-4900-b191-2c366e5812f2
https://www.globenewswire.com/NewsRoom/AttachmentNg/72091977-b8c2-42b4-8a55-036b5e80766a

• Strategic partnership expected to accelerate global scale up of Factorial’s all-solid-state Solstice™ platform
• Mitsui Kinzoku, one of the few companies in the world holding foundational solid-state electrolyte technology, signs Joint Development Agreement to help power the scale up
• The partnership positions Solstice™ at the center of an industry wide push toward commercializing all solid-state batteries.

BOSTON, Sept. 17, 2026 (GLOBE NEWSWIRE) — Factorial Energy Inc. (“Factorial”) (Nasdaq: FAC), a global leader in solid-state battery technology, today announced a strategic partnership with Mitsui Kinzoku Company, Limited to support the industrialization of its Solstice™ all-solid-state battery platform.

Mitsui Kinzoku is a leading producer of sulfide-based solid electrolytes for all-solid-state batteries, one of few companies worldwide with foundational technology in this space, and already the global leader in ultra-thin copper foil, with an estimated 90% share of the semiconductor market for that foil. That materials science expertise underpins its A-SOLiD™ sulfide solid electrolyte, unveiled in 2016 and advancing toward mass production at a dedicated plant in Saitama, Japan.

“I am very pleased that we have been able to enter into this joint development agreement with Factorial,” said Dr. Kiyotaka Yasuda, Senior Executive Officer, General Manager, Business Creation Division of Mitsui Kinzoku Company, Limited. “Batteries are a key technology for realizing an electrified society, but significant technical challenges still remain. That is precisely why we believe it is necessary to go beyond the extension of existing technologies and take on the challenge of creating new value. By leveraging Mitsui Kinzoku’s long-established expertise in materials and manufacturing technologies and combining it with Factorial’s advanced technological capabilities, we aim to accelerate the realization of next-generation batteries.”

Factorial remains the fabless innovator across the platform, leading cell design, process development, supply chain qualification, line integration, and manufacturing validation.

“Battery innovation can’t be done by one single company,” said Siyu Huang, CEO of Factorial. “It’s driven by the entire supply chain and, increasingly, by an entire industry coalition. Mitsui Kinzoku’s foundational electrolyte technology brings critical materials expertise to our work to move Solstice™ toward commercial deployment. We’re not just building a battery. We’re building the connective thread that helps the whole industry move forward together.”

As robotics, aerospace systems, and AI-enabled infrastructure ask more of the physical world, energy is fast becoming the defining constraint on what’s possible. Factorial calls this the emergence of the energy layer – the battery infrastructure needed to power the next era of mobility, aerospace and physical intelligence. Built for that layer, Solstice™, Factorial’s sulfide-based all-solid-state battery platform, delivers high energy density and improved thermal stability, with proprietary dry-cathode processing enabling more cost-effective manufacturing.

This collaboration builds on Factorial’s recent momentum, including strategic investments from IQT and POSCO Future M; its first commercial orders for passenger vehicles in January and for aerospace in July; expanded automotive and industrialization partnership programs; and its June 2026 Nasdaq listing under the ticker symbol FAC.

About Factorial Energy
Factorial Energy (Nasdaq: FAC) is a leading American solid-state battery innovator backed by IQT – the not-for-profit strategic investor for the U.S. national security community and America’s allies – and Mercedes-Benz, Stellantis, Hyundai, and Kia. Through its proprietary FEST® and Solstice™ platforms, engineered for scalable manufacturing, Factorial delivers industry-leading performance across aerospace, energy storage and mobility applications. In 2026, Factorial’s initial drone flight test achieved 30% longer range, and the company secured its first commercial orders in both aerospace and passenger vehicle applications. In automotive, Mercedes-Benz’ real-world road testing in a lightly modified test vehicle achieved over 1,200 km of range on a single charge, with the technology also successfully integrated into a fully built Dodge Charger Daytona demonstration vehicle in partnership with Stellantis.. For more information, visit www.factorialenergy.com.

About Mitsui Kinzoku
Mitsui Kinzoku is a Japan-based global materials company and a leading manufacturer of non-ferrous metals and advanced materials, providing innovative solutions primarily for the automotive and electronics industries. Leveraging its core strengths in non-ferrous metals, functional materials, and recycling technologies, the company develops and manufactures a wide range of high-performance products, including automotive components, semiconductor materials, battery materials, and engineered materials. With a strong focus on innovation, environmental responsibility, and resource circulation, Mitsui Kinzoku collaborates with partners around the world to create new value and will continue to contribute to the realization of a sustainable society.

Forward-Looking Statements
Certain statements in this communication may be considered forward-looking statements. Forward-looking statements generally relate to future events or Factorial’s future financial or operating performance, including expectations regarding manufacturing capabilities, commercialization plans, business strategy, customer programs, partnerships, supply-chain development and production readiness. In some cases, forward-looking statements can be identified by terms such as “may,” “should,” “expect,” “intend,” “will,” “estimate,” “anticipate,” “believe,” “predict,” “project,” “target,” “plan,” “potentially” or similar terminology. These statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied. Factorial undertakes no obligation to update forward-looking statements except as required by law.

Factorial has used, and intends to continue to use, its Investor Relations website (https://ir.factorialenergy.com), as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. Information on or that can be accessed through Factorial’s Investor Relations website, or that is contained in any website to which a hyperlink is provided herein is not part of this press release, and the inclusion of Factorial’s Investor Relations website address, and any hyperlinks are only inactive textual references.

Factorial IR Contact:
IR@factorialenergy.com

Factorial Media Contact:
Factorial@antennagroup.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7c718db9-61c2-4ef9-8111-13e68368dabb